Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

The trauma severity model: An ensemble machine learning approach to risk prediction.

Gorczyca MT, Toscano NC, Cheng JD.

Comput Biol Med. 2019 May;108:9-19. doi: 10.1016/j.compbiomed.2019.02.025. Epub 2019 Mar 6.

PMID:
30965177
2.

Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.

Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD Jr, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD.

Lancet Oncol. 2018 Dec;19(12):1641-1653. doi: 10.1016/S1470-2045(18)30576-X. Epub 2018 Nov 12.

3.

Fetal Survival in Second-Trimester Termination of Pregnancy Without Feticide.

Springer S, Gorczyca ME, Arzt J, Pils S, Bettelheim D, Ott J.

Obstet Gynecol. 2018 Mar;131(3):575-579. doi: 10.1097/AOG.0000000000002503.

PMID:
29420410
4.

Local neuropeptide signaling modulates serotonergic transmission to shape the temporal organization of C. elegans egg-laying behavior.

Banerjee N, Bhattacharya R, Gorczyca M, Collins KM, Francis MM.

PLoS Genet. 2017 Apr 6;13(4):e1006697. doi: 10.1371/journal.pgen.1006697. eCollection 2017 Apr.

5.

Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial.

Robak T, Warzocha K, Govind Babu K, Kulyaba Y, Kuliczkowski K, Abdulkadyrov K, Loscertales J, Kryachok I, Kłoczko J, Rekhtman G, Homenda W, Błoński JZ, McKeown A, Gorczyca MM, Carey JL, Chang CN, Lisby S, Gupta IV, Grosicki S.

Leuk Lymphoma. 2017 May;58(5):1084-1093. doi: 10.1080/10428194.2016.1233536. Epub 2016 Oct 12.

PMID:
27731748
6.

Nanoscale investigation of the interaction of colistin with model phospholipid membranes by Langmuir technique, and combined infrared and force spectroscopies.

Freudenthal O, Quilès F, Francius G, Wojszko K, Gorczyca M, Korchowiec B, Rogalska E.

Biochim Biophys Acta. 2016 Nov;1858(11):2592-2602. doi: 10.1016/j.bbamem.2016.07.015. Epub 2016 Jul 30.

7.

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy.

Jewell RC, Kipps TJ, Dürig J, Griskevicius L, Stilgenbauer S, Smolej L, Mayer J, Hess G, Hernandez-Ilizaliturri FJ, Padmanabhan-Iyer S, Fang L, Goldstein N, Gorczyca M, Gupta I, Lisby S, Wierda WG; Hx-CD20-407 Study Investigators.

Leuk Lymphoma. 2017 Feb;58(2):348-356. Epub 2016 Jul 7.

PMID:
27389174
8.

Structure - membrane activity relationship in a family of peptide-based gemini amphiphiles: An insight from experimental and theoretical model systems.

Korchowiec B, Gorczyca M, Korchowiec J, Rubio-Magnieto J, Lotfallah AH, Luis SV, Rogalska E.

Colloids Surf B Biointerfaces. 2016 Oct 1;146:54-62. doi: 10.1016/j.colsurfb.2016.05.040. Epub 2016 May 17.

PMID:
27259159
9.

Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia.

Österborg A, Udvardy M, Zaritskey A, Andersson PO, Grosicki S, Mazur G, Kaplan P, Steurer M, Schuh A, Montillo M, Kryachok I, Middeke JM, Kulyaba Y, Rekhtman G, Gorczyca M, Daly S, Chang CN, Lisby S, Gupta I.

Leuk Lymphoma. 2016 Sep;57(9):2037-46. doi: 10.3109/10428194.2015.1122783. Epub 2016 Jan 19.

PMID:
26784000
10.

The selective interactions of cationic tetra-p-guanidinoethylcalix[4]arene with lipid membranes: theoretical and experimental model studies.

Korchowiec B, Gorczyca M, Rogalska E, Regnouf-de-Vains JB, Mourer M, Korchowiec J.

Soft Matter. 2016 Jan 7;12(1):181-90. doi: 10.1039/c5sm01891a.

PMID:
26451711
11.

Impact of two different saponins on the organization of model lipid membranes.

Korchowiec B, Gorczyca M, Wojszko K, Janikowska M, Henry M, Rogalska E.

Biochim Biophys Acta. 2015 Oct;1848(10 Pt A):1963-73. doi: 10.1016/j.bbamem.2015.06.007. Epub 2015 Jun 6.

12.

A Study of the Interaction between a Family of Gemini Amphiphilic Pseudopeptides and Model Monomolecular Film Membranes Formed with a Cardiolipin.

Gorczyca M, Korchowiec B, Korchowiec J, Trojan S, Rubio-Magnieto J, Luis SV, Rogalska E.

J Phys Chem B. 2015 Jun 4;119(22):6668-79. doi: 10.1021/acs.jpcb.5b02575. Epub 2015 May 20.

PMID:
25959677
13.

Molecular organization of nalidixate conjugated calixarenes in bacterial model membranes probed by molecular dynamics simulation and Langmuir monolayer studies.

Korchowiec B, Korchowiec J, Gorczyca M, Regnouf de Vains JB, Rogalska E.

J Phys Chem B. 2015 Feb 19;119(7):2990-3000. doi: 10.1021/jp507151r. Epub 2015 Feb 2.

PMID:
25602178
14.

A large-scale behavioral screen to identify neurons controlling motor programs in the Drosophila brain.

Flood TF, Gorczyca M, White BH, Ito K, Yoshihara M.

G3 (Bethesda). 2013 Oct 3;3(10):1629-37. doi: 10.1534/g3.113.006205.

15.

A single pair of interneurons commands the Drosophila feeding motor program.

Flood TF, Iguchi S, Gorczyca M, White B, Ito K, Yoshihara M.

Nature. 2013 Jul 4;499(7456):83-7. doi: 10.1038/nature12208. Epub 2013 Jun 9.

16.

Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood.

Knappe S, Gorczyca ME, Jilma B, Derhaschnig U, Hartmann R, Palige M, Scheiflinger F, Dockal M.

Thromb Haemost. 2013 Mar;109(3):450-7. doi: 10.1160/TH12-07-0529. Epub 2013 Jan 24.

PMID:
23348798
17.

[Endovascular treatment of wide-necked posterior cerebral artery aneurysm using stent].

Gorczyca M, Popiela TJ, Urbanik A.

Przegl Lek. 2012;69(7):289-91. Polish.

PMID:
23276016
18.

Interaction of a β-lactam calixarene derivative with a model eukaryotic membrane affects the activity of PLA2.

Korchowiec B, Gorczyca M, Ben Salem A, Regnouf de Vains JB, Rogalska E.

Colloids Surf B Biointerfaces. 2013 Mar 1;103:217-22. doi: 10.1016/j.colsurfb.2012.10.045. Epub 2012 Nov 2.

PMID:
23201740
19.

Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.

Gorczyca ME, Nair SC, Jilma B, Priya S, Male C, Reitter S, Knoebl P, Gilbert JC, Schaub RG, Dockal M, McGinness KE, Pabinger I, Srivastava A.

J Thromb Haemost. 2012 Aug;10(8):1581-90. doi: 10.1111/j.1538-7836.2012.04790.x.

20.

A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura.

Jilma-Stohlawetz P, Gilbert JC, Gorczyca ME, Knöbl P, Jilma B.

Thromb Haemost. 2011 Sep;106(3):539-47. doi: 10.1160/TH11-02-0069. Epub 2011 Aug 11.

PMID:
21833442
21.

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.

Wierda WG, Kipps TJ, Dürig J, Griskevicius L, Stilgenbauer S, Mayer J, Smolej L, Hess G, Griniute R, Hernandez-Ilizaliturri FJ, Padmanabhan S, Gorczyca M, Chang CN, Chan G, Gupta I, Nielsen TG, Russell CA; 407 Study Investigators.

Blood. 2011 Jun 16;117(24):6450-8. doi: 10.1182/blood-2010-12-323980. Epub 2011 Apr 15.

22.

Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura.

Jilma-Stohlawetz P, Gorczyca ME, Jilma B, Siller-Matula J, Gilbert JC, Knöbl P.

Thromb Haemost. 2011 Mar;105(3):545-52. doi: 10.1160/TH10-08-0520. Epub 2010 Dec 21.

PMID:
21174003
23.

Rapid activity-dependent modifications in synaptic structure and function require bidirectional Wnt signaling.

Ataman B, Ashley J, Gorczyca M, Ramachandran P, Fouquet W, Sigrist SJ, Budnik V.

Neuron. 2008 Mar 13;57(5):705-18. doi: 10.1016/j.neuron.2008.01.026.

24.

Selected methods for the anatomical study of Drosophila embryonic and larval neuromuscular junctions.

Budnik V, Gorczyca M, Prokop A.

Int Rev Neurobiol. 2006;75:323-65. Review. No abstract available.

PMID:
17137935
25.

Nuclear trafficking of Drosophila Frizzled-2 during synapse development requires the PDZ protein dGRIP.

Ataman B, Ashley J, Gorczyca D, Gorczyca M, Mathew D, Wichmann C, Sigrist SJ, Budnik V.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7841-6. Epub 2006 May 8.

26.

The Drosophila Wnt, wingless, provides an essential signal for pre- and postsynaptic differentiation.

Packard M, Koo ES, Gorczyca M, Sharpe J, Cumberledge S, Budnik V.

Cell. 2002 Nov 1;111(3):319-30.

27.

Recruitment of scribble to the synaptic scaffolding complex requires GUK-holder, a novel DLG binding protein.

Mathew D, Gramates LS, Packard M, Thomas U, Bilder D, Perrimon N, Gorczyca M, Budnik V.

Curr Biol. 2002 Apr 2;12(7):531-9.

28.
29.

Synaptic targeting and localization of discs-large is a stepwise process controlled by different domains of the protein.

Thomas U, Ebitsch S, Gorczyca M, Koh YH, Hough CD, Woods D, Gundelfinger ED, Budnik V.

Curr Biol. 2000 Sep 21;10(18):1108-17.

30.

The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction.

Torroja L, Packard M, Gorczyca M, White K, Budnik V.

J Neurosci. 1999 Sep 15;19(18):7793-803.

31.

The gene mod(mdg4) affects synapse specificity and structure in Drosophila.

Gorczyca M, Popova E, Jia XX, Budnik V.

J Neurobiol. 1999 Jun 5;39(3):447-60.

32.

Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism.

Pinto IL, Jarvest RL, Clarke B, Dabrowski CE, Fenwick A, Gorczyca MM, Jennings LJ, Lavery P, Sternberg EJ, Tew DG, West A.

Bioorg Med Chem Lett. 1999 Feb 8;9(3):449-52.

PMID:
10091700
33.

Essential role for dlg in synaptic clustering of Shaker K+ channels in vivo.

Tejedor FJ, Bokhari A, Rogero O, Gorczyca M, Zhang J, Kim E, Sheng M, Budnik V.

J Neurosci. 1997 Jan 1;17(1):152-9.

34.

Regulation of synapse structure and function by the Drosophila tumor suppressor gene dlg.

Budnik V, Koh YH, Guan B, Hartmann B, Hough C, Woods D, Gorczyca M.

Neuron. 1996 Oct;17(4):627-40.

35.

The Drosophila tumor suppressor gene, dlg, is involved in structural plasticity at a glutamatergic synapse.

Guan B, Hartmann B, Kho YH, Gorczyca M, Budnik V.

Curr Biol. 1996 Jun 1;6(6):695-706.

36.

Chemical and pharmacological properties of new tetrahydropyrimido-[2,1-f]-purines.

Pawłowski M, Drabczyńska A, Gorczyca M, Malec D, Modzelewski J.

Pharmazie. 1995 Jul;50(7):453-5.

PMID:
7675886
37.

Octopamine immunoreactivity in the fruit fly Drosophila melanogaster.

Monastirioti M, Gorczyca M, Rapus J, Eckert M, White K, Budnik V.

J Comp Neurol. 1995 May 29;356(2):275-87.

38.
39.

The influence of new 9-(omega-[4-(2-pyrimidinyl)-1-piperazinyl]alkyl) pyrimidino[2,1-f]purines on the central nervous system.

Malec D, Modzelewski J, Drabczyńska A, Pawłowski M, Gorczyca M.

Pol J Pharmacol. 1995 Mar-Apr;47(2):169-73.

PMID:
8688890
40.

The Drosophila tumor suppressor gene dlg is required for normal synaptic bouton structure.

Lahey T, Gorczyca M, Jia XX, Budnik V.

Neuron. 1994 Oct;13(4):823-35.

41.
42.

Synthesis and pharmacological screening of novel 10-substituted diazepino-[2,1-f]-purines.

Pawłowski M, Drabczyńska A, Gorczyca M, Malec D, Modzelewski J.

Acta Pol Pharm. 1994;51(4-5):385-91.

PMID:
7701952
43.
44.

Ultrastructure of neuromuscular junctions in Drosophila: comparison of wild type and mutants with increased excitability.

Jia XX, Gorczyca M, Budnik V.

J Neurobiol. 1993 Aug;24(8):1025-44. Erratum in: J Neurobiol 1994 Jul;25(7):893-5.

45.
47.

Synthesis and preliminary pharmacological assessment of novel 9-alkylamino substituted pyrimidino-[2,1-f]-purines.

Drabczyńska A, Pawłowski M, Gorczyca M, Malec D, Modzelewski J.

Pol J Pharmacol Pharm. 1992 Sep-Oct;44(5):487-503.

PMID:
1297113
48.

Dual muscarinic and nicotinic action on a motor program in Drosophila.

Gorczyca MG, Budnik V, White K, Wu CF.

J Neurobiol. 1991 Jun;22(4):391-404.

PMID:
1679841
49.

Single-channel K+ currents in Drosophila muscle and their pharmacological block.

Gorczyca MG, Wu CF.

J Membr Biol. 1991 May;121(3):237-48.

PMID:
1865488
50.

Synthesis and preliminary pharmacological assessment of novel 9-substituted pyrimidino-[2,1-f]-purines.

Pawłowski M, Drabczyńska A, Gorczyca M, Malec D, Modzelewski J.

Pol J Pharmacol Pharm. 1991 Jan-Feb;43(1):61-70.

PMID:
1771164

Supplemental Content

Loading ...
Support Center